Rotation Medical is a technology company.
Rotation Medical has raised $39.0M across 2 funding rounds.
Rotation Medical has raised $39.0M in total across 2 funding rounds.
Rotation Medical has raised $39.0M in total across 2 funding rounds.
Rotation Medical's investors include Amzak Health Investors, Avoro Ventures, Canaan Partners, EQT Life Sciences, Flagship Pioneering, Mott Family Capital, New Enterprise Associates, OrbiMed, Westlake Village BioPartners, Jason Henrichs.
Rotation Medical developed the Rotation Medical Rotator Cuff System, a bioinductive implant for treating rotator cuff disease.[1][2][3] The collagen-based implant, about the size of a postage stamp, is delivered arthroscopically to partial-thickness tears, inducing growth of new tendon-like tissue to thicken tendons and potentially slow disease progression; for full-thickness tears, it augments traditional repairs.[1][3] It serves orthopedic surgeons and patients undergoing the 650,000 annual U.S. rotator cuff procedures (growing 5-6% yearly), addressing unmet needs in tendon biology.[1][3] The FDA-cleared device launched in 2014, achieved rapid adoption, and drove growth via funding like a $27.4M Series B and $12M extension before Smith & Nephew acquired it in 2017 for $125M upfront plus up to $85M contingent.[1][3][4]
Founded in 2006 in Minnesota (formerly Denali Medical), Rotation Medical emerged to tackle rotator cuff disease with innovative collagen scaffolds.[2][6] Under CEO Martha Shadan, the company secured FDA 510(k) clearance and raised significant capital, including $27.2M in Series B (2014) and a $12M extension (2016) from investors like New Enterprise Associates, Life Science Partners, and Pappas Ventures.[3][4][5] Pivotal moments included the 2014 commercialization, which sparked "rapid growth and very positive momentum" with strong physician adoption, setting the stage for its 2017 acquisition by Smith & Nephew to integrate into their Sports Medicine portfolio.[1][3]
Rotation Medical rode the wave of regenerative medicine in orthopedics, targeting the massive rotator cuff repair market amid rising procedure volumes from aging populations and active lifestyles.[1][3] Timing aligned with advances in bioinductive materials and minimally invasive surgery, filling gaps in traditional repairs that often fail due to poor tendon healing.[1][8] Market forces like 5-6% annual U.S. growth favored scalable, biology-focused solutions; its acquisition by Smith & Nephew amplified influence, embedding the tech in a global medtech leader's portfolio to accelerate adoption and spur further Sports Medicine innovations.[1]
Post-2017 acquisition, Rotation Medical's technology has likely scaled globally within Smith & Nephew, enhancing rotator cuff outcomes and expanding to EU markets.[1] Trends like AI-driven imaging, personalized implants, and biologics integration will shape its evolution, potentially reducing re-tear rates in a market exceeding 650,000 procedures yearly.[1] Its legacy as a disruptive startup underscores how targeted medtech can transform chronic orthopedic challenges, paving the way for next-gen tendon regeneration therapies.
Rotation Medical has raised $39.0M across 2 funding rounds. Most recently, it raised $12.0M Series B in August 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2016 | $12.0M Series B | Amzak Health Investors, Avoro Ventures, Canaan Partners, EQT Life Sciences, Flagship Pioneering, Mott Family Capital, New Enterprise Associates, OrbiMed, Westlake Village BioPartners, Jason Henrichs | |
| Jul 1, 2014 | $27.0M Series B | Amzak Health Investors, Avoro Ventures, Canaan Partners, EQT Life Sciences, Flagship Pioneering, Mott Family Capital, New Enterprise Associates, OrbiMed, Westlake Village BioPartners, Jason Henrichs |